Journal of Virology, November 2001, p. 10856-10869, Vol. 75, No. 22
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.22.10856-10869.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Department of Microbiology, University of Colorado Health Sciences Center, Denver, Colorado 80262,1 and Department of Molecular Biology, Princeton University, Princeton, New Jersey 085442
Received 22 May 2001/Accepted 15 August 2001
| |
ABSTRACT |
|---|
|
|
|---|
The alphaherpesvirus Us4 gene encodes glycoprotein G (gG), which is conserved in most viruses of the alphaherpesvirus subfamily. In the swine pathogen pseudorabies virus (PRV), mutant viruses with internal deletions and insertions in the gG gene have shown no discernible phenotypes. We report that insertions in the gG locus of the attenuated PRV strain Bartha show reduced virulence in vivo and are defective in their ability to spread from cell to cell in a cell-type-specific manner. Similar insertions in the gG locus of the wild-type PRV strain Becker had no effect on the ability of virus infection to spread between cells. Insertions in the gG locus of the virulent NIA-3 strain gave results similar to those found with the Bartha strain. To examine the role of gG in cell-to-cell spread, a nonsense mutation in the gG signal sequence was constructed and crossed into the Bartha strain. This mutant, PRV157, failed to express gG yet had cell-to-cell spread properties indistinguishable from those of the parental Bartha strain. These data indicated that, while insertions in the gG locus result in decreased cell-to-cell spread, the phenotype was not due to loss of gG expression as first predicted. Analysis of gene expression upstream and downstream of gG revealed that expression of the upstream Us3 protein is reduced by insertion of lacZ or egfp at the gG locus. By contrast, expression of the gene immediately downstream of gG, Us6, which encodes glycoprotein gD, was not affected by insertions in gG. These data indicate that DNA insertions in gG have polar effects and suggest that the serine/threonine kinase encoded by the Us3 gene, and not gG, functions in the spread of viral infection between cells.
| |
INTRODUCTION |
|---|
|
|
|---|
The alphaherpesviruses comprise a large number of medically and economically important viruses that include the human pathogens herpes simplex virus (HSV) and varicella-zoster virus, the bovine pathogen bovine herpesvirus 1 (BHV-1), and the swine pathogen pseudorabies virus (PRV). Alphaherpesviruses infect cells by two general mechanisms: free virions can bind to specific receptors on the surface of the cell, resulting in the fusion of the virus envelope with the cell membrane, or virus infection can spread directly from an infected cell to an adjacent, uninfected cell (73). The latter process is referred to as cell-to-cell spread. Cell-to-cell spread can be distinguished from infection by free virions because the former can occur in the presence of neutralizing antibody, whereas the latter cannot. Cell-to-cell spread of virus infection is important for the spread of infection through tissues and is utilized in the transsynaptic passage of virus through the nervous system (reviewed in reference 16). The spread of virus infection from cell to cell allows evasion from the neutralizing antibodies in an immunized host, for example, during reactivation from latency. Furthermore, the spread of infection through the formation of syncytia can occur very quickly. Uninfected cells are recruited into syncytia in much less time than it takes for an infected cell to produce virions. In the face of a competent immune system, it is advantageous for the virus to spread quickly.
Cell-to-cell spread of alphaherpesvirus infection can occur by at least two processes. In the first, the plasma membrane of the infected cell fuses with that of adjacent, uninfected cells, resulting in the formation of giant, multinucleated syncytia (74). Syncytium formation occurs in the lesions caused by PRV, HSV, and varicella-zoster virus in their natural hosts (67). Not all cell types fuse when infected by these viruses, indicating that a specific cellular environment is required. In the second process, infection is thought to spread at cell junctions without the formation of a syncytium (14). This nonsyncytial form of cell-to-cell spread is often seen in cultured cells. The molecular mechanism by which cell-to-cell spread of infection occurs has been shown to be different from the process of infection by free virions in that the specific requirements for viral membrane proteins differ for each process. The spread of infection from cell to cell requires a much larger repertoire of viral proteins than does infection by free virions. Infection by free virions requires glycoprotein B (gB), gD, and the gH/gL complex (73). Similarly, spread from cell to cell also requires gB and gH/gL. The requirements for gD in this process are variable, depending on the alphaherpesvirus (11, 14, 52, 58, 62, 77, 81).
Viral proteins gB, gD, gE/gI, gH/gL, gK, gM, UL20, UL24, and UL45 all participate in the spread of HSV infection between cells (reviewed in references 74 and 77). Precisely how these molecules function in this process is unclear. Deletion of gE and gI has no measurable effect on the entry of virus into cells yet has profound effects on cell-to-cell spread of infection in certain cell types (2, 14, 15, 79, 88). Recent evidence suggests that gE and gI sort virions to epithelial cell junctions, thereby facilitating cell-to-cell spread (24, 47, 86). Mutations in gB, gK, UL20, or UL24 result in viruses that form syncytia on many cultured cell lines (74). Turner and colleagues have used a Cos cell transfection system to study the requirements for HSV type 1 (HSV-1) syncytium formation (81). These studies have shown that expression of gB, gD, gH, and gL is necessary and sufficient to mediate membrane fusion. Similar results were obtained when comparable experiments were performed using the analogous glycoproteins from HSV-2 (51). These studies also highlight the viral fusion machinery as a tightly regulated complex during a viral infection. For example, infection of Cos cells with wild-type virus does not result in extensive syncytium formation, despite high-level expression of gB, gD, gH, and gL in the membranes of infected cells. There is good evidence that gE/gI, gK, gM, and UL45 serve as regulators of the viral fusion machinery and that UL20 is required for efficient processing of gK (2, 11, 12, 17, 20, 22, 28, 31, 61, 88).
We have identified two cell lines that define new requirements for the
spread of virus infection between cells. These cell lines are
Georgia bovine kidney (GBK) and Madin-Darby bovine kidney (MDBK).
Wild-type PRV strains form giant, multinuclear syncytia on GBK or MDBK
cell monolayers. When the glycoprotein gE or gI was deleted from
PRV, large nonsyncytial plaques formed on these cells, supporting the
findings of previous studies (2, 11, 88). The two cell
lines also display a cell-type-specific phenotype that involves
nonsyncytial cell-to-cell spread. In some viral genetic backgrounds,
insertion of the
-galactosidase gene (lacZ) or the gene
for enhanced green fluorescent protein (EGFP) (egfp) in the
gG gene results in a striking reduction of plaques without affecting
syncytium formation. This phenotype is not apparent on monolayers of
the swine kidney cell line PK15. Insertions of lacZ or
egfp result in a gG-null phenotype but also reduce the expression of the upstream Us3 gene. The plaque size is due not to loss
of gG but rather to the reduction of expression of Us3, a unique
protein kinase.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Viruses and cells.
The virus strains used in this study are
listed in Table 1. PRV strains expressing
-galactosidase, Becker-Blu, Bartha-Blu, and PRV99-Blu have been
described elsewhere (3, 32, 75). The construction of PRV
strains expressing EGFP has been described recently (71).
Briefly, PRV151, PRV152, and PRV155 were constructed by homologous
recombination between a plasmid containing an EGFP expression cassette
cloned into the middle of the PRV gG gene and the PRV genome. Briefly,
a 2.6-kbp SalI fragment from PRV-Becker containing the 3'
end of the Us3 gene, the entire gG gene, and the 5'end of the gD gene
was cloned into the SalI site of pBB3 [a modified
pGEM-5zf(+) derivative in which the PstI site and NotI site have been deleted] to generate pBB4. Next, a
2.3-kbp NsiI fragment from pEGFP-N1 (Clontech, Palo Alto,
Calif.) containing the cytomegalovirus immediate-early promoter, EGFP
sequences, and a simian virus 40 poly(A) signal was cloned into a
unique PstI site in pBB4 to generate pII1. This leaves about
840 bp of PRV sequence upstream of the EGFP expression cassette and
1,750 bp downstream of the EGFP expression cassette available for
homologous recombination with the viral genome. The plasmid pII1 was
digested with SalI and cotransfected with purified
PRV-Becker DNA (PRV151), PRV-Bartha DNA (PRV152), or M201 DNA (PRV155)
into PK15 cells. Virus produced after cotransfection was plated on PK15
cells, and plaques expressing EGFP were identified with the aid of an inverted epifluorescence microscope. Virus was isolated from
EGFP-expressing plaques and subjected to three rounds of purification.
Southern blot analysis using the Becker SalI fragment from
pBB4 as a probe was performed to verify that the EGFP expression
cassette had recombined appropriately into the PRV genome.
|
Intraocular injection of chick embryos. Intraocular injections were performed on E12 White Leghorn chicken embryos exactly as described previously (3). Immediately prior to injection, virus stocks were thawed and sonicated briefly, and cells and cellular debris were removed by brief centrifugation in a microfuge. Animals were injected in the vitreous humor of the right eye with various amounts of virus ranging from 102 to 106 PFU in a total volume of 1 µl. Virulence was measured by determining both the mean time to death after injection of 105 PFU and the 50% lethal dose (LD50). The LD50 was defined as the number of PFU required to kill 50% of the animals within 168 h, a time just prior to hatching. LD50s were calculated using the graphic interpolation method of Reed and Muench (64). Experimental protocols were approved by the Animal Welfare Committee and were consistent with the regulations of the American Association for the Accreditation of Laboratory Animal Care and those in the Animal Welfare Act (Public Law 99-198). All animals were confined to a biosafety-level-2 laboratory.
Primary retinal cultures. Retinae (~12) were removed from E8 embryos and were collected in 2 ml of Hanks' buffered salt solution without Ca2+ and Mg2+. Trypsin (Gibco/BRL) was added to the Hanks' buffered salt solution to a final concentration of 1%, and the retinae were incubated at 37°C for 5 min. After trypisinization, 10 ml of DMEM-10% FCS-5% chicken serum (CS) was added to the retinae and the tissue was pelleted by centrifugation at 600 × g for 7 min at room temperature. Cells were resuspended in 2 ml of DMEM-10% FCS-5% CS and were triturated 10 times with a sterile Pasteur pipette. The volume was brought up to 24 ml with DMEM-10% FCS-5% CS, and 2 ml was plated per well onto 6-well culture dishes (Falcon), each well containing a poly-L-lysine-treated 22-mm-diameter glass coverslip. Cells were incubated at 37°C in a 5% CO2 environment for 3 days prior to infection with PRV.
Plaque assays.
Serial 10-fold dilutions of virus were
prepared in DMEM-10% FCS. One hundred microliters of each dilution
was added to a well of a 6-well cluster dish containing a 85 to 95%
confluent monolayer of either PK15, GBK, or MDBK cells, and the dishes
were returned to the incubator. The cells and inoculum were rocked
every 10 min for 1 h to ensure that the monolayer did not become
dry, and then 3 ml of DMEM-10% FCS-1% carboxy-methylcellulose was
added to each well and the plates were returned to the incubator for 48 h. Cells were fixed and stained in 70% methanol-0.5%
methylene blue. For detection of
-galactosidase activity, infected
monolayers were rinsed three times with phosphate-buffered saline and
were then fixed in 4% formaldehyde for 10 min at room temperature. Following fixation, cells were rinsed three times with 3 ml of phosphate-buffered saline and 1 ml of substrate buffer added (1 mg of
5-bromo-4-chloro-3-indolyl-
-D-galactopyranoside
[X-Gal]/ml, 10 mM potassium ferrocyanide, 10 mM potassium
ferricyanide, 2 mM MgCl2, 0.01% sodium
deoxycholate, and 0.02% IGEPAL CA-630 (NP-40) in 0.1 M phosphate
buffer, pH 7.4). Cells were incubated in substrate buffer overnight
(~16 h) at 37°C. Substrate buffer was removed and replaced with
phosphate-buffered saline until the cells were photographed. For
EGFP-expressing viruses, plaques were photographed directly at 48 h postinfection using a Nikon TE200 inverted epifluorescence microscope
equipped with a cooled charge-coupled device camera.
Analysis of gG expression. Expression of gG protein by parental, mutant, and repaired viruses was examined by labeling infected PK15 cells with [35S]methionine. At 3 h postinfection, cells were incubated with [35S]methionine at 50 µCi/ml in methionine-free medium for 30 min. At the end of the labeling period, monolayers were rinsed three times with serum-free medium, serum-free medium was added to the cells, and the plates were returned to the incubator. After 1 h the medium was collected, clarified of cells and cellular debris by centrifugation, and analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and autoradiography. At the time that the medium was harvested, 4.5 h postinfection, significant amounts of newly synthesized virions were not present in the medium.
RNA analysis. RNA was isolated from mock-infected or infected (multiplicity of infection = 10) MDBK cells at 3 and 6 h postinfection using the Trizol reagent (Gibco/BRL). Dishes (diameter, 100 mm) containing approximately 5 × 106 cells were used for each sample. Ten micrograms of total RNA from each sample was denatured in 50% formamide, 2.2 M formaldehyde, and 25 mM sodium phosphate buffer pH 7.1, and was separated on a 1% agarose-formaldehyde gel and transferred to a nylon membrane as described elsewhere (45). The blot was hybridized to a biotinylated double-stranded DNA probe corresponding to the Us3b open reading frame, which was prepared as follows: the Us3b open reading frame was amplified by PCR using the forward primer 5'CGGAATTCGTTGTCGCGCGTCCACGCCCAGC3' and the reverse primer 5'AAGGAAAAAAGCGGCCGCAGGTGTGTGTGTCCTACCGCTCG3'. The PCR product was biotinylated using the NEBlot Phototope Kit (New England Biolabs). Bands hybridizing to the biotinylated Us3b probe were detected using the Phototope-Star detection kit (New England Biolabs) according to the manufacturer's instructions.
Preparation of Us3 antisera. Antiserum against a Us3 peptide was raised in rabbits and affinity purified by Bethyl Laboratories (Montgomery, Tex.). Briefly, the peptide RRPSADEILNFG corresponding to amino acids 373 to 384 of Us3a and 319 to 330 of Us3b was synthesized, conjugated to keyhole limpet hemocyanin, and used to immunize two New Zealand White rabbits.
Western blot analysis. MDBK cells growing in 100-mm-diameter culture dishes (~5 × 106 cells) were infected with PRV at a multiplicity of infection of 10. At 3 and 6 h postinfection, the medium was removed from the dish and the cells were rinsed three times with cold phosphate-buffered saline. Cold lysis buffer (750 µl) (10 mM Tris, 150 mM NaCl, 1% IGEPAL CA-630, 1% sodium deoxycholate, pH 7.4) was added, and the cells were incubated on ice for 10 min. SDS-PAGE sample buffer was added to portions of lysates, and these were subjected to SDS-PAGE on 10% gels as described elsewhere (37). Following electrophoresis, protein in gels was transferred to polyvinylidene difluoride membranes using a Bio-Rad semidry transfer apparatus following the manufacturer's instructions. Membranes were blocked overnight in Tris-buffered saline-Tween (50 mM Tris, 200 mM NaCl, 0.05% Tween 20) containing 3% bovine serum albumin. Proteins were visualized by using rabbit (for Us3 and gD) or goat (for gB) polyclonal primary antibodies and enhanced chemiluminescence detection as recommended by the manufacturer (Renaissance system; NEN).
| |
RESULTS |
|---|
|
|
|---|
A PRV vaccine strain, Bartha, with an insertion at the gG locus
shows reduced virulence in a chicken embryo eye model.
A chicken
embryo eye model was established to study alphaherpesvirus neuronal
spread and virulence (3). In this model, virus is injected
directly into the right eye of embryonic day-12 embryos through a small
window opened in the eggshell. After injection, the window is sealed,
eggs are returned to an incubator, and the virulence properties and the
capacity of virus to spread from the eye to the brain are measured. The
virulence of several PRV strains was tested in two ways: first, by the
determination of LD50, and second, by measuring
the mean time to death after inoculation with 105
PFU of virus. To facilitate the identification of infected cells and
tissue, a number of the strains used express
-galactosidase at the
gG locus. The PRV gG locus was chosen as a site to insert the
lacZ gene because viruses with deletions or insertions in gG
display wild-type virulence in any system studied to date and because
it has been used extensively by other groups studying PRV (27,
49, 75, 78; J. P. Card, R. R. Miselis, and L. W. Enquist, unpublished observations).
|
A PRV strain with an insertion at the gG locus has defects in
cell-to-cell spread.
To understand the basis for different
virulence properties exhibited by PRV mutants in the chicken embryo eye
model, we examined infection of chick primary retinal cultures. The
retina is the primary site of viral replication in the chicken embryo
eye model. Four days after plating, the cells had established two
distinct layers: large flat Müller glial cells grew on the
culture dish and neurons spread over this glial cell layer. To
facilitate the identification of infected cells, these cultures were
infected with PRV strains that express EGFP from the gG locus. Like the virus strains with lacZ insertions, these viruses do not
express gG. PRV151 is an EGFP-expressing derivative of the virulent
Becker strain, and PRV152 is an EGFP-expressing derivative of the
Bartha vaccine strain (71). Four-day-old mixed retinal
cultures were infected with PRV151 and PRV152. Twenty-four
hours after infection, the cells were fixed and stained with Hoechst
33258 to identify nuclei, and the DNA and EGFP signals were visualized
by fluorescence microscopy (Fig. 1A).
Infection by PRV151 resulted in the formation of multinuclear syncytia.
By contrast, PRV152-infected cells did not form syncytia. This
observation provided evidence that the reduced virulence of the Bartha
strains in the chicken embryo eye model may reflect defects in
cell-to-cell spread.
|
|
|
Reduced replication or decreased infection efficiency does not account for tiny-nonsyncytial-plaque phenotype. Small plaques can arise due to a reduced ability of the virus to replicate, a decrease in the efficiency with which virus infects cells, or a specific defect in the spread of virus from cell to cell. Two of these possibilities were tested directly. To determine if Bartha-Blu had a growth defect relative to Bartha on monolayers of GBK cells, single-step growth analysis was performed. The data indicated that both the rate of infectious virus production and the total amount of infectious virus produced in cells and released into the medium were similar for Bartha and Bartha-Blu (Fig. 3B). In fact, Bartha-Blu consistently produced slightly more infectious virus than Bartha, both in the cells and culture medium. From these data, we concluded that the small-plaque phenotype exhibited by Bartha-Blu was not due to a reduced ability of the virus to replicate in GBK cells.
To eliminate the possibility that Bartha strains with insertions in gG had a reduced ability to infect GBK cells, the specific infectivities of the Becker, Becker-Blu, Bartha, and Bartha-Blu were measured. For every 100 plaques that formed on PK15 cells, approximately 120 plaques formed on monolayers of GBK cells when equivalent inocula were used. This plating efficiency held for all virus strains tested. Decreased efficiency of infection does not account for the reduced ability of plaques to form on GBK cells.Introduction of a nonsense mutation into the gG gene of the Bartha strain has no effect on cell-to-cell spread. Is the gG protein required for the efficient spread of Bartha viruses from cell to cell? This question was addressed by introducing a stop codon seven codons into the Bartha gG gene by site-directed mutagenesis. PRV156 is a Bartha derivative that expresses EGFP from the gG locus and, like Bartha-Blu, PRV152, and PRV154, produces tiny nonsyncytial plaques on monolayers of GBK cells. The virus with the nonsense mutation in gG is PRV157, and the repaired PRV156 strain is PRV156R.
Because gG is secreted from infected cells in abundance, expression of this glycoprotein can be assayed by analysis of infected-tissue culture supernatants (5, 6). The results from this experiment are shown in Fig. 4A. gG is secreted from cells in three predominant forms of approximately 180, 75, and 50 kDa that arise as a result of proteolytic cleavage and other posttranslational modifications, including sulfation and glycosylation (5, 63, 78). As expected, cells infected with the Bartha strain and the repaired PRV156 strain PRV156R synthesized and secreted gG into the medium. By contrast, cells infected with the EGFP-expressing PRV156 strain or the PRV157 strain, which has a nonsense mutation at codon 7 of gG, did not secrete any detectable gG. Equal loading of samples was confirmed by an internal loading control (Fig. 4A, asterisk). These viruses were next tested for their ability to form plaques on monolayers of GBK cells.
|
Us3 mRNA levels are not affected by insertions in gG locus.
A
cartoon of the gG locus and surrounding genes is shown in Fig.
5. The transcription of the Us3 and Us4
genes has been characterized in detail for both PRV and HSV, and the
patterns of transcription from this region are strikingly similar
between viruses (65, 82, 87).
|
|
Us3 protein expression is substantially reduced in PRV strains with
insertions in gG.
Protein extracts were prepared from PRV-infected
MDBK cells at 6 h postinfection and were run on an SDS-10% PAGE
gel. Protein in gels was transferred to polyvinylidene difluoride
membranes and was probed using antiserum raised against gD, gB, or Us3
(Fig. 7). Insertions in gG had no effect
on the steady-state levels of either gD or gB, as evidenced by the fact
that similar amounts of protein were detected in Bartha- and
Bartha-Blu-infected cell extracts (Fig. 7A and B). By contrast,
steady-state levels of Us3 were significantly reduced in PRV strains
that had either lacZ or egfp insertions in gG,
regardless of whether the strain was derived from Becker or Bartha
(Fig. 7C). Curiously, the relative mobility of Us3 identified in
Becker- versus Bartha-derived strains differed in that Bartha's Us3
migrated more rapidly in the SDS-PAGE gel. The significance of this
finding is under investigation. Results obtained with infected PK15
cell extracts were indistinguishable from those obtained with MDBK
cells.
|
Relationship between gE/gI and insertions in gG in spread of
infection between cells.
The data so far suggest that Us3
functions in the spread of viral infection between MDBK or GBK cells.
gE and gI also participate in the cell-to-cell spread of infection in
MDBK and GBK cells. To investigate the relationship between the role of
gE/gI versus that of Us3 in cell-to-cell spread, we first examined the
effect of insertions in gG in viruses that encode gE and gI. PRV158 is a derivative of the Bartha strain in which the deletion of gI, gE, Us9,
and Us2 has been repaired with Becker sequences. PRV159 is a derivative
of PRV158 that has an egfp insertion in the gG locus. Plaque
morphologies of Becker, PRV151, PRV158, and PRV159 were examined on
monolayers of MDBK cells (Fig. 8A).
Restoration of the gI, gE, Us9, and Us2 genes in the Bartha strain does
not fully rescue plaque size on MDBK cells, as evidenced by the
observation that PRV158 plaques are considerably smaller than plaques
formed by Becker on MDBK cells. This data suggest that other mutations in the Bartha strain contribute to its small plaque size on MDBK cells.
Insertion of egfp into these strains causes a modest
reduction in plaque size (compare Becker versus PRV151 and PRV158
versus PRV159, Fig. 8A). These data indicate that expression of gE/gI, Us9, and Us2 in the Bartha strain can overcome the effects of an
insertion in gG (compare PRV159, Fig. 8A, to PRV152, Fig. 8B).
|
| |
DISCUSSION |
|---|
|
|
|---|
We report that insertions in the gG locus of PRV can affect the spread of virus infection from cell to cell in a cell-type-specific manner. Interestingly, this phenotype was not due to loss of gG expression, because a mutant with a nonsense mutation in the gG signal sequence had no spread defect. We then noted that Us3 protein expression was dramatically reduced in PRV strains with either lacZ or egfp insertions in gG. By contrast, the gD gene, located immediately downstream of gG and belonging to a family of transcripts different from that of Us3 and gG, was not affected by insertions in the gG gene. Analysis of mRNA synthesized in cells infected with gG insertion mutants indicated that, although Us3 transcript size increased as expected, the steady-state amount of Us3 transcript was not markedly reduced. Apparently, insertions in the gG locus of PRV affect export of the altered Us3 message from the nucleus to the cytoplasm or result in inefficient translation of the altered Us3 transcripts. Further experiments will be required to determine the mechanism by which Us3 expression is attenuated in viruses with insertions in gG.
Early studies on HSV and PRV gG indicated that it was not required for efficient growth in culture; mutant viruses had no discernible growth defects (2, 44, 78, 84). Modest phenotypes were observed in vivo for HSV gG mutants, however. For example, an HSV-1 strain with a transposon insertion in gG was attenuated after intracranial inoculation of mice and an HSV-1 strain with a lacZ insertion in gG had reduced ability to invade the peripheral nervous system after inoculation of the mouse ear pinna (2, 84). By contrast, PRV strains with mutations in gG have had no discernible phenotypes in most model systems or in the natural host (27, 49, 75, 78; Card et al., unpublished). Recently, Kim and colleagues described differences in the virulence properties between the Bartha and the Bartha-Blu strain in the rat eye model. Bartha-Blu, which has a lacZ insertion in gG, took longer to kill animals, and infected animals had increased time until the appearance of symptoms (25). In the present study, we noted a significant difference in the virulence properties between the Bartha and Bartha-Blu strains in the chicken embryo eye model. Bartha-Blu had an LD50 that was 60-fold greater than that of the parental Bartha strain. Whether the in vivo phenotypes described here or previously are a result of a loss of gG function or reduced expression of Us3 remains to be clarified.
In other alphaherpesviruses, such as HSV and BHV-1, the Us3 message polyadenylation signal is located downstream of gG (39, 65). Accordingly, one might predict that insertions or deletions in the gG genes of these viruses might also affect the expression of Us3. Recently, two groups have described functions for gG using mutant viruses with insertions or deletions in the gG open reading frame (55, 56, 80). Tran and coworkers have described a gG mutant of HSV-1 that has a defect in the entry of virus into polarized MDCK cells from the apical surface (80). MDCK cells are extraordinarily refractory to infection compared to Vero or HEp-2 cells. Indeed, roughly 20,000-fold more virus is required to infect MDCK cells from the apical surface and greater than 100,000-fold more virus is required to infect these cells from the basolateral surface than are required for Vero cells, for example. Perhaps alternative or "suboptimal" virus entry pathways are functioning in the infection of MDCK cells by HSV. The gG mutant RAS104 used in the study by Tran et al. (80) is a gG deletion mutant. In light of the present study, it is possible that the deletion affects mRNA structure and stability. It may be that the upstream Us3 mRNA is affected by the gG deletion. Examination of Us3 expression in the RAS104 strain or the analysis of a HSV-1 strain with a nonsense mutation in gG would clarify this point. Nakamichi and colleagues have ascribed two functions to BHV-1 gG (55, 56). A mutant BHV-1 strain, BHV-1/TF9-5, has a small deletion in gG into which the PRV thymidine kinase gene was inserted. This virus has a defect in cell-to-cell spread on MDBK cells, which is similar to what we observed in this study (56). In addition, the BHV-1/TF9-5 strain fails to protect RK13 rabbit kidney cells from BHV-1-induced apoptosis (56). It may be that the effects on BHV-1 biology observed by these scientists are due at least in part to effects on Us3 expression. In the aforementioned studies, the gG insertion and deletion viruses were repaired, which resulted in complete reversion to the parental phenotype. However, if the gG insertion-deletion phenotype were repaired, any effect of these mutations on Us3 expression would also be repaired.
Smith and Enquist noted that insertion of either an EGFP expression cassette or bacterial artificial chromosome sequences into an intergenic region immediately downstream of the PRV Us9 gene markedly attenuated Us9 expression (72). Removal of these foreign sequences restored Us9 expression. These observations further emphasize the risk of unanticipated alterations in gene expression when inserting new sequences into the viral genome.
The Us3 gene encodes a serine/threonine kinase (18, 46). Us3 has been shown to play a role in the inhibition of HSV-induced apoptosis (19, 21, 23, 38). The specific functions of this molecule are not known; however, it is not essential for growth of PRV or HSV in many cultured cell lines (26, 44, 57). Interestingly, a PRV strain with a mutation in Us3 grows well in swine kidney cell lines but displays a strong reduction in growth in an immortalized swine B-cell line (26). This cell-type-specific defect is intriguing because the cell-to-cell spread defects of gG insertion mutants that we observe are evident only in some cell types. Moreover, the Us3 protein kinase is important for viral egress from the nucleus in specialized cell types (59, 83). For example, a PRV strain with an inactivated Us3 gene has a defect in the maturation of virions in porcine nasal mucosa explant cultures (59). Why do we see cell-type-specific effects of insertions in gG? It may be that cell types in which gG insertion mutants spread normally synthesize a kinase that can replace Us3. Alternatively, cells that make small plaques may produce an inhibitor of Us3 function that is absent in cells that show normal virus spread.
A major substrate of the HSV Us3 protein kinase is the membrane-associated UL34 protein (60). UL34 is an essential protein in HSV and PRV required for the primary envelopment of nucleocapsids at the inner nuclear membrane (29, 68). There is no evidence to support the idea that UL34 functions in cell-to-cell spread, however. Other viral molecules that are substrates for the HSV Us3 protein kinase are the UL12 alkaline nuclease and the protein encoded by the Us9 gene (9, 10). As observed with UL34 mutants, mutations in UL12 affect capsid envelopment at the nuclear membrane (70). Us9 has been shown to be required for the spread of PRV in certain neuronal circuits (7). However, previous studies have shown that deletion of Us9 has no influence on the ability of PRV to spread from cell to cell in GBK or MDBK cells. Our hypothesis is that one or more viral proteins required for cell-to-cell spread are modified by the Us3 protein kinase. It is likely that as-yet-unidentified viral and cellular substrates exist for Us3 and that one or more of these contribute to cell-to-cell spread.
It is well established that gE and gI participate in cell-to-cell
spread of infection in polarized epithelial cells and in the nervous
system (14, 15, 16, 24, 33, 47, 79, 85, 86). Recent
results from Johnson and colleagues suggest that the carboxy terminus
of gE is required for targeting virus to adherens junctions in
polarized epithelial cells (24). Takahashi and coworkers
have reported that the alphaherpesvirus receptor nectin-1
/HveC
localizes to adherens junctions (76). Moreover, these
workers have determined that interaction of the cytoplasmic tail of
nectin-1
/HveC with afadin, which serves to link nectin-1
/HveC to
the actin cytoskeleton, is required for efficient cell-to-cell spread
of HSV-1 but not for virus entry (69). Taken together, these data strongly suggest that cell-to-cell spread of infection occurs at adherens junctions. We report here that expression of gE and
gI is sufficient to overcome the effects of insertions in gG in the
Bartha strain, whereas in the absence of gE and gI, both Bartha and
NIA-3 are sensitive to insertions in gG (Fig. 8). One interpretation of
these data is that an alternative, gE/gI-independent cell-to-cell-spread pathway exists in GBK and MDBK cells. It follows that insertions in gG disrupt this gE/gI-independent spread pathway and
that Us3 activity is required for this mode of cell-to-cell spread.
Alternatively, Us3 may also function at cell-to-cell spread at adherens
junctions, but expression of gE and gI is sufficient to overcome any
requirement for Us3 in GBK and MDBK cells. Examination of the effects
of Us3 expression on the structure and function of adherens junctions
may provide clues to the role of Us3 in cell-to-cell spread.
Because both the Bartha and NIA-3 strains are affected by insertions in gG, it may be that the Becker strain encodes a function that can compensate for this insertion. Alternatively, Bartha and NIA-3 may encode a function that perturbs cell-to-cell spread in the absence of Us3. Suppressor mutants of Bartha-Blu, PRV152, and PRV156 that tolerate insertions in gG arise at high frequency (about 1/2,000 plaques). These suppressors retain the gG insertion, do not have genomic reorganization at the Us3 or gG loci, synthesize reduced amounts of Us3 relative to the Bartha strain, and do not have enhanced replication kinetics (G. L. Demmin and B. W. Banfield, unpublished observations). Taken together, these observations suggest that the suppressor mutations reside in a second site and affect cell-to-cell spread, specifically. It may be that the Becker strain is genotypically similar to the suppressor mutants at this second site. Marker transfer experiments are under way to identify genes from the Becker strain and the suppressor mutants that compensate for insertions in gG. Our prediction is that genes with suppressor mutations will participate in a Us3-dependent cell-to-cell spread pathway.
| |
ACKNOWLEDGMENTS |
|---|
We thank Kevin Durand for expert technical assistance and Ilya Iofin and Alexander Costa for providing plasmids pII1 and pAC2, respectively. We thank L. Jacobs for kindly providing PRV strain M201. We acknowledge Robert Ho and Jean Schwarzbauer for generous use of microscopy equipment and Joe Goodhouse for help with confocal microscopy. We are grateful to Tony Minson for suggesting the possibility that insertions in the PRV gG gene might affect Us3 expression. Many thanks go to Renée Finnen and David Wentworth for critical reviews of the manuscript.
While at Princeton University, B.W.B. was supported by a postdoctoral fellowship from the Medical Research Council of Canada. This work was supported by NINDS grant 1R0133506 to L.W.E. and NIAID grant 1RO1AI48626 to B.W.B.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Department of Microbiology, University of Colorado Health Sciences Center, Campus Box B175, 4200 E. Ninth Ave., Denver, CO 80262. Phone: (303) 315-5285. Fax: (303) 315-6785. E-mail: Bruce.Banfield{at}uchsc.edu.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Babic, N., B. Klupp, A. Brack, T. C. Mettenleiter, G. Ugolini, and A. Flamand. 1996. Deletion of glycoprotein gE reduces the propagation of pseudorabies virus in the nervous system of mice after intranasal inoculation. Virology 219:279-284[CrossRef][Medline]. |
| 2. |
Balan, P.,
N. Davis-Poynter,
S. Bell,
H. Atkinson,
H. Browne, and T. Minson.
1994.
An analysis of the in vitro and in vivo phenotypes of mutants of herpes simplex virus type 1 lacking glycoproteins gG, gE, gI or the putative gJ.
J. Gen. Virol.
75:1245-1258 |
| 3. |
Banfield, B. W.,
G. S. Yap,
A. C. Knapp, and L. W. Enquist.
1998.
A chicken embryo eye model for the analysis of alphaherpesvirus neuronal spread and virulence.
J. Virol.
72:4580-4588 |
| 4. | Bartha, A., S. Belák, and J. Benyeda. 1969. Trypsin and heat resistance of some strains of the virus group. Acta Vet. Hung. 19:97-99. |
| 5. | Bennett, L. M., J. G. Timmins, D. R. Thomsen, and L. E. Post. 1986. The processing of pseudorabies virus glycoprotein gX in infected cells and in an uninfected cell line. Virology 155:707-715[CrossRef][Medline]. |
| 6. | Ben-Porat, T., and A. S. Kaplan. 1970. Synthesis of proteins in cells infected with herpesvirus. V. Viral glycoproteins. Virology 41:265-273[CrossRef][Medline]. |
| 7. |
Brideau, A. D.,
J. P. Card, and L. W. Enquist.
2000.
Role of pseudorabies virus us9, a type II membrane protein, in infection of tissue culture cells and the rat nervous system.
J. Virol.
74:834-845 |
| 8. |
Card, J. P.,
M. E. Whealy,
A. K. Robbins, and L. W. Enquist.
1992.
Pseudorabies virus envelope glycoprotein gI influences both neurotropism and virulence during infection of the rat visual system.
J. Virol.
66:3032-3041 |
| 9. |
Daikoku, T.,
R. Kurachi,
T. Tsurumi, and Y. Nishiyama.
1994.
Identification of a target protein of US3 protein kinase of herpes simplex virus type 2.
J. Gen. Virol.
75:2065-2068 |
| 10. | Daikoku, T., Y. Yamashita, T. Tsurumi, and Y. Nishiyama. 1995. The US3 protein kinase of herpes simplex virus type 2 is associated with phosphorylation of the UL12 alkaline nuclease in vitro. Arch. Virol. 140:1637-1644[CrossRef][Medline]. |
| 11. |
Davis-Poynter, N.,
S. Bell,
T. Minson, and H. Browne.
1994.
Analysis of the contributions of herpes simplex virus type 1 membrane proteins to the induction of cell-cell fusion.
J. Virol.
68:7586-7590 |
| 12. |
Dietz, P.,
B. G. Klupp,
W. Fuchs,
B. Kollner,
E. Weiland, and T. C. Mettenleiter.
2000.
Pseudorabies virus glycoprotein K requires the UL20 gene product for processing.
J. Virol.
74:5083-5090 |
| 13. | Dijkstra, J. M., T. C. Mettenleiter, and B. G. Klupp. 1997. Intracellular processing of pseudorabies virus glycoprotein M (gM): gM of strain Bartha lacks N-glycosylation. Virology 237:113-122[CrossRef][Medline]. |
| 14. |
Dingwell, K. S.,
C. R. Brunetti,
R. L. Hendricks,
Q. Tang,
M. Tang,
A. J. Rainbow, and D. C. Johnson.
1994.
Herpes simplex virus glycoproteins E and I facilitate cell-to-cell spread in vivo and across junctions of cultured cells.
J. Virol.
68:834-845 |
| 15. | Dingwell, K. S., L. C. Doering, and D. C. Johnson. 1995. Glycoproteins E and I facilitate neuron-to-neuron spread of herpes simplex virus. J. Virol. 69:7087-7098[Abstract]. |
| 16. | Enquist, L. W., P. J. Husak, B. W. Banfield, and G. A. Smith. 1999. Infection and spread of alphaherpesviruses in the nervous system. Adv. Virus Res. 51:237-347. |
| 17. |
Foster, T. P., and K. G. Kousoulas.
1999.
Genetic analysis of the role of herpes simplex virus type 1 glycoprotein K in infectious virus production and egress.
J. Virol.
73:8457-8468 |
| 18. |
Frame, M. C.,
F. C. Purves,
D. J. McGeoch,
H. S. Marsden, and D. P. Leader.
1987.
Identification of the herpes simplex virus protein kinase as the product of viral gene US3.
J. Gen. Virol.
68:2699-2704 |
| 19. |
Galvan, V., and B. Roizman.
1998.
Herpes simplex virus 1 induces and blocks apoptosis at multiple steps during infection and protects cells from exogenous inducers in a cell-type-dependent manner.
Proc. Natl. Acad. Sci. USA
95:3931-3936 |
| 20. |
Haanes, E. J.,
C. M. Nelson,
C. L. Soule, and J. L. Goodman.
1994.
The UL45 gene product is required for herpes simplex virus type 1 glycoprotein B-induced fusion.
J. Virol.
68:5825-5834 |
| 21. | Hata, S., A. H. Koyama, H. Shiota, A. Adachi, F. Goshima, and Y. Nishiyama. 1999. Antiapoptotic activity of herpes simplex virus type 2: the role of US3 protein kinase gene. Microbes Infect. 1:601-607[CrossRef][Medline]. |
| 22. | Hutchinson, L., C. Roop-Beauchamp, and D. C. Johnson. 1995. Herpes simplex virus glycoprotein K is known to influence fusion of infected cells, yet is not on the cell surface. J. Virol. 69:4556-4563[Abstract]. |
| 23. |
Jerome, K. R.,
R. Fox,
Z. Chen,
A. E. Sears,
H.-Y. Lee, and L. Corey.
1999.
Herpes simplex virus inhibits apoptosis through the action of two genes, Us5 and Us3.
J. Virol.
73:8950-8957 |
| 24. |
Johnson, D. C.,
M. Webb,
T. W. Wisner, and C. Brunetti.
2001.
Herpes simplex virus gE/gI sorts nascent virions to epithelial cell junctions, promoting virus spread.
J. Virol.
75:821-833 |
| 25. |
Kim, J. S.,
L. W. Enquist, and J. P. Card.
1999.
Circuit-specific coinfection of neurons in the rat central nervous system with two pseudorabies virus recombinants.
J. Virol.
73:9521-9531 |
| 26. | Kimman, T. G., N. De Wind, T. De Bruin, Y. de Visser, and J. Voermans. 1994. Inactivation of glycoprotein gE and thymidine kinase or the US3-encoded protein kinase synergistically decreases in vivo replication of pseudorabies virus and the induction of protective immunity. Virology 205:511-518[CrossRef][Medline]. |
| 27. |
Kimman, T. G.,
N. de Wind,
N. Oei-Lie,
J. M. A. Pol,
A. J. M. Berns, and A. L. J. Gielkens.
1992.
Contributions of single genes within the unique short region of Aujeszky's disease virus (suid herpes virus 1) to virulence, pathogenesis and immunogenicity.
J. Gen. Virol.
73:243-251 |
| 28. |
Klupp, B. G.,
J. Baumeister,
P. Dietz,
H. Granzow, and T. C. Mettenleiter.
1998.
Pseudorabies virus glycoprotein gK is a virion structural component involved in virus release but is not required for entry.
J. Virol.
72:1949-1958 |
| 29. |
Klupp, B. G.,
H. Granzow, and T. C. Mettenleiter.
2000.
Primary envelopment of pseudorabies virus at the nuclear membrane requires the UL34 gene product.
J. Virol.
74:10063-10073 |
| 30. | Klupp, B. G., B. Lomniczi, N. Visser, W. Fuchs, and T. C. Mettenleiter. 1995. Mutations affecting the UL21 gene contribute to avirulence of pseudorabies virus vaccine strain Bartha. Virology 212:466-473[CrossRef][Medline]. |
| 31. |
Klupp, B. G.,
R. Nixdorf, and T. C. Mettenleiter.
2000.
Pseudorabies virus glycoprotein M inhibits membrane fusion.
J. Virol.
74:6760-6768 |
| 32. | Knapp, A. C., and L. W. Enquist. 1997. Pseudorabies virus recombinants expressing functional virulence determinants gE and gI from bovine herpesvirus 1.1. J. Virol. 71:2731-2739[Abstract]. |
| 33. | Knapp, A. C., P. J. Husak, and L. W. Enquist. 1997. The gE and gI homologs from two alphaherpesviruses have conserved and divergent neuroinvasive properties. J. Virol. 71:5820-5827[Abstract]. |
| 34. |
Kritas, S. K.,
H. J. Nauwynck, and M. B. Pensaert.
1995.
Dissemination of wild-type gC-, gE-, and gI-deleted mutants of Aujeszky's disease virus in the maxillary nerve and trigeminal ganglion of pigs after intranasal inoculation.
J. Gen. Virol.
76:2063-2066 |
| 35. | Kritas, S. K., M. B. Pensaert, and T. C. Mettenleiter. 1994. Invasion and spread of single glycoprotein deleted mutants of Aujeszky's disease virus (ADV) in the trigeminal nervous pathway of pigs after intranasal inoculation. Vet. Microbiol. 40:323-334[CrossRef][Medline]. |
| 36. |
Kritas, S. K.,
M. B. Pensaert, and T. C. Mettenleiter.
1994.
Role of envelope glycoproteins gI, gp63 and gIII in the invasion and spread of Aujeszky's disease virus in the olfactory nervous pathway of the pig.
J. Gen. Virol.
75:2319-2327 |
| 37. | Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (London) 227:680-685[CrossRef][Medline]. |
| 38. |
Leopardi, R.,
C. Van Sant, and B. Roizman.
1997.
The herpes simplex virus 1 protein kinase US3 is required for protection from apoptosis induced by the virus.
Proc. Natl. Acad. Sci. USA
94:7891-7896 |
| 39. | Leung-Tack, P., J. C. Audonnet, and M. Riviere. 1994. The complete DNA sequence and the genetic organization of the short unique region (US) of the bovine herpesvirus type 1 (ST strain). Virology 199:409-421[CrossRef][Medline]. |
| 40. |
Lomniczi, B.,
M. L. Blankenship, and T. Ben-Porat.
1984.
Deletions in the genomes of pseudorabies virus vaccine strains and existence of four isomers of the genomes.
J. Virol.
49:970-979 |
| 41. | Lomniczi, B., A. S. Kaplan, and T. Ben-Porat. 1987. Multiple defects in the genome of pseudorabies virus can affect virulence without detectably affecting replication in cell culture. Virology 161:181-189[CrossRef][Medline]. |
| 42. |
Lomniczi, B.,
S. Watanabe,
T. Ben-Porat, and A. S. Kaplan.
1984.
Genetic basis of the neurovirulence of pseudorabies virus.
J. Virol.
52:198-205 |
| 43. |
Lomniczi, B.,
S. Watanabe,
T. Ben-Porat, and A. S. Kaplan.
1987.
Genome location and identification of functions defective in the Bartha vaccine strain of pseudorabies virus.
J. Virol.
61:796-801 |
| 44. |
Longnecker, R., and B. Roizman.
1987.
Clustering of genes dispensable for growth in culture in the S component of the HSV-1 genome.
Science
236:573-576 |
| 45. | Maniatis, T. C., E. F. Fritsch, and J. Sambrook. 1982. Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y. |
| 46. |
McGeoch, D. J., and A. J. Davison.
1986.
Alphaherpesviruses possess a gene homologous to the protein kinase gene family of eukaryotes and retroviruses.
Nucleic Acids Res.
14:1765-1777 |
| 47. |
McMillan, T. N., and D. C. Johnson.
2001.
Cytoplasmic domain of herpes simplex virus gE causes accumulation in the trans-Golgi network, a site of virus envelopment and sorting of virions to cell junctions.
J. Virol.
75:1928-1940 |
| 48. |
Mettenleiter, T. C.,
N. Lukacs, and H. J. Rziha.
1985.
Pseudorabies virus avirulent strains fail to express a major glycoprotein.
J. Virol.
56:307-311 |
| 49. |
Mettenleiter, T. C., and I. Rauh.
1990.
A glycoprotein gX- -galactosidase fusion gene as insertional marker for rapid identification of pseudorabies virus mutants.
J. Virol. Methods
30:55-66 |